Understanding the key factors driving prescription drug costs is the first step to finding effective solutions for reining in rising prices. Read about the 8 trends in our recent whitepaper; https://lnkd.in/eyppjZCu
From the rise of specialty drugs to the impact of patent expirations, here are 8 evolving trends in #pharmacy benefits that employers need to know. Read more in our whitepaper 🔗 https://lnkd.in/eyppjZCu #TheBaldwinGroup #ProtectingThePossible #EmployeeBenefits
From the emergence of specialty drugs to the effect of patent expirations, here are 8 developing trends in the pharmacy benefits sphere that employers should be aware of. Dive deeper into the topic within our whitepaper 🔗 https://lnkd.in/eyppjZCu #pharmacybenefits #JGSInsurance #InsuranceIsntBoring
From the rise of specialty drugs to the impact of patent expirations, here are 8 evolving trends in #pharmacy benefits that employers need to know. Read more in our whitepaper 🔗 https://lnkd.in/eyppjZCu #TheBaldwinGroup #ProtectingThePossible #EmployeeBenefits
From the emergence of specialty drugs to the effect of patent expirations, here are 8 developing trends in the pharmacy benefits sphere that employers should be aware of. Dive deeper into the topic within our whitepaper 🔗 https://lnkd.in/eyppjZCu #pharmacybenefits #AHTInsurance
From the rise of specialty drugs to the impact of patent expirations, here are 8 evolving trends in #pharmacy benefits that employers need to know. Read more in our whitepaper 🔗 https://lnkd.in/eyppjZCu #TheBaldwinGroup #ProtectingThePossible #EmployeeBenefits
What are the 8 evolving trends in pharmacy benefits you need to know? Read more in our whitepaper 🔗 https://lnkd.in/eyppjZCu #TheBaldwinGroup #pharmacy #employeebenefits
From the rise of specialty drugs to the impact of patent expirations, here are 8 evolving trends in #pharmacy benefits that employers need to know. Read more in our whitepaper 🔗 https://lnkd.in/eyppjZCu #TheBaldwinGroup #ProtectingThePossible #EmployeeBenefits
From the rise of specialty drugs to the impact of patent expirations, here are 8 evolving trends in #pharmacy benefits that employers need to know. Read more in our whitepaper 🔗 https://lnkd.in/eyppjZCu #TheBaldwinGroup #ProtectingThePossible #EmployeeBenefits
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> FTC investigates Teva over patents, doubling down on 'bogus' Orange Book listings >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #healthcare #productmarketing #pharma
Stay ahead in the pharma industry with our comprehensive DrugPatentWatch Week in Review. Get insights into the latest patent expirations, new drug approvals, and market trends. Equip yourself with the knowledge to make informed decisions. #PharmaIndustry #PatentExpiration #DrugApprovals #WeeklyUpdate
Pharmacy benefits costs are increasing due to multiple factors including utilization and a lack of availability of biosimilars. Expert Christopher Brown (McAteer) discusses manufacturer pricing, the cost of R&D, and drug patents. For tips on reducing pharmacy benefits costs, check out our article: https://lnkd.in/gR4g27Fv #wsinsights #PBM #pharmacybenefits
💡 Next up, Debjani Banerjee, Deputy General Manager from Glenmark Pharmaceuticals, took us through Crafting Effective Patent Litigation Strategies for Generics and Biosimilars. This keynote showed that in the world of generics, success is as much about strategy in the courtroom as it is in the lab. It’s all about outsmarting the competition with innovative IP approaches! #PatentStrategy #BiosimilarsSuccess #GenericsLitigation #IPInnovation
It's time for a change! 🌟 United States Senators from both parties are pushing for patent reform to stop pharmaceutical companies from keeping prices high with minor patent modifications. At a recent Senate Judiciary Committee hearing, experts highlighted the need for better coordination between the FDA and USPTO. Bills introduced by US Sens. Welch, Braun, and Klobuchar aim to limit excessive patents and make way for affordable generics. Let's support this fight for affordable healthcare! 💊 Read More: https://lnkd.in/ghaYVAtn
Thoughts on this? >> FTC investigates Teva over patents, doubling down on 'bogus' Orange Book listings >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #productmarketing #biotech
Entrepreneurial Healthcare Professional | PBM | Self-Funding | Employee Benefits
3moLove to see the value you place on transparency and PBM's that work with your clients interest first. Keep up the great work Meredith.